Broncalt®, class II medical device, in patients with chronic upper airways disease: a survey in clinical practice

Inflammation and infection are common pathogenic mechanisms involved in many otorhinolaryngological (ORL) chronic diseases. Broncalt® is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It could exert a safe and effective anti-i...

Full description

Saved in:
Bibliographic Details
Published in:Acta bio-medica de l'Ateneo Parmense 2019-07, Vol.90 (Suppl 7), p.30-35
Main Authors: Gian, Franco Cupido, Matteo, Gelardi, Ignazio, La Mantia, Salvo, Emanuele Aragona, Claudio, Vicini, Giorgio, Ciprandi
Format: Article
Language:English
Subjects:
Original
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Inflammation and infection are common pathogenic mechanisms involved in many otorhinolaryngological (ORL) chronic diseases. Broncalt® is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It could exert a safe and effective anti-inflammatory, washing, and antimicrobial activity by virtue of these components. Therefore, the aim of the current survey, conducted in clinical practice of 84 Italian ORL centers, was to evaluate its safety and efficacy in the treatment of patients with chronic upper airways disease. The 1,817 (958 males, mean age 49 years) patients were evaluated at baseline (T0) and after one (T1) and two (T2) weeks of treatment, they were treated or not treated with Broncalt®. Signs and symptoms severity were measured by visual analogue scale. Broncalt® significantly, quickly, and safely diminished the clinical features in all sub-groups (p
ISSN:0392-4203
2531-6745
DOI:10.23750/abm.v90i7-S.8655